The medical sharps market is projected to grow from USD 10.9 billion in 2026 to USD 45.3 billion by 2036, at a CAGR of 15.3%. Hypodermic needles will dominate with a 28.0% market share, while drug delivery & injections will lead the applications segment with a 36.0% share.